Description
Recently published results from multiple studies have impacted the standard of care for neoadjuvant and adjuvant treatment approaches in surgically resectable non-small cell lung cancer (NSCLC).  We will summarize these results and focus on real world, practical application of these data in patient care.

Moderator & Speakers